CAI Caris Life Sciences, Inc.
$33.22+1.13%
Last close: · regular session · Last 60 sessions
After-hours $28.71 -13.58% ·
- Float
- 108.6M
- Last filing
- 8-K · Nov 4, 2026
Latest SEC filings for CAI
| 8-K | Current report | |
| 10-Q | Quarterly report | |
| 8-K | Current report | |
| SCHEDULE 13G/A | ||
| 8-K | Current report | |
| 10-Q | Quarterly report | |
| ABS-15G | ||
| 8-A12B | ||
| CERT | ||
| 8-K | Current report |
Dilution today: new offering filings and reverse splits
Float: 108.6M shares. Latest SEC filing: 8-K on Nov 4, 2026. CAI closed at $33.22 (+1.13%) on Nov 4, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for CAI in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 1,769
- Website: https://www.carislifesciences.com
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
Latest CAI news
- Caris targets $1.04B-$1.05B 2026 revenue as it guides to ~65,000 Q4 clinical cases Read article
- Caris Life Sciences,?Inc. (CAI) Q3 Earnings and Revenues Top Estimates Read article
- Caris Life Sciences, Inc. Q3 2026 Earnings Preview Read article
- Analysts Estimate Caris Life Sciences,?Inc. (CAI) to Report a Decline in Earnings: What to Look Out for Read article
- Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026 Read article
- Caris Life Sciences, Inc. $CAI Shares Newly Bought by City Center Advisors LLC Read article
Recent dilution filers
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.